Up next

Autoplay

Unanswered questions in DCIS progression

2 Views • 07/16/23
Share
Embed
administrator
administrator
Subscribers
0

Tanjina Kader, PhD, Peter MacCallum Cancer Centre, Melbourne, Australia, discusses a recent breakthrough in ductal carcinoma in situ (DCIS) implicating myoepithelial invasion as a prognostic marker for DCIS progression to invasive cancer. More research needs to be carried out to characterize this process, with a focus on the role of cellular communication with surrounding stromal and immune cells. This interview took place at the American Association for Cancer Research Annual Meeting in New Orleans, LA.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay